Pierre Fabre Médicament has a total of 80 patent applications. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), Serbia and Singapore. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are NEWBIO THERAPEUTICS INC, GREENE MARK I and LYTIX BIOPHARMA AS.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 69 | |
#2 | Serbia | 9 | |
#3 | Singapore | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Measurement | |
#5 | Machines | |
#6 | Medical technology |
# | Name | Total Patents |
---|---|---|
#1 | Goetsch Liliane | 14 |
#2 | Jouhanneaud Alexandra | 10 |
#3 | Dupont-Passelaigue Elisabeth | 7 |
#4 | Klinguer-Hamour Christine | 6 |
#5 | Junquero Didier | 6 |
#6 | Perez Michel | 6 |
#7 | Kaloun El Bachir | 5 |
#8 | Imbert Thierry | 5 |
#9 | Sokoloff Pierre | 5 |
#10 | Guminski Yves | 5 |
Publication | Filing date | Title |
---|---|---|
EP3710011A1 | Pentacyclic triterpenes for the treatment of an oral disease | |
EP3288593A1 | Conjugate of monomethyl auristatin f and trastuzumab and its use for the treatment of cancer | |
EP3046917A1 | Quinazoline derivatives and their use as dna methyltransferase inhibitors |